INS and systemic sclerosis: In conclusion, to the best of our knowledge, this is the first time that whole-body insulin sensitivity is assessed in SSc by using a validated and reliable method, thus providing relevant and unique data to the current limited knowledge about glucose homeostasis in SSc.